Donna Shu‐Han Lin

Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors

Donna Shu‐Han Lin, Jen‐Kuang Lee, Wen‐Jone Chen · Diabetologia · 2021 · 76 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta‐Analysis of Randomized Controlled Trials

Donna Shu‐Han Lin, Hao‐Yun Lo, Kuan‐Chih Huang et al. · Journal of the American Heart Association · 2023 · 34 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors

Donna Shu‐Han Lin, An‐Li Yu, Hao-Yun Lo et al. · Diabetologia · 2022 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Effects of Mineralocorticoid Receptor Antagonists on Cardiovascular Outcomes in Patients with End-Stage Renal Disease and Heart Failure

Donna Shu‐Han Lin, Fang‐Ju Lin, Yu‐Sheng Lin et al. · European Journal of Heart Failure · 2022 · 25 citations

Medicine, Cardiology, Nephrology +17

Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis

Hao-Yun Lo, Yu‐Sheng Lin, Donna Shu‐Han Lin et al. · JAMA Network Open · 2022 · 21 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14